About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | COVID-19 Clinical Trials in Philadelphia | 93 Studies

Clinical Trials COVID-19Philadelphia

COVID-19 Clinical Trials in Philadelphia

Find 93 clinical trials for covid-19 near Philadelphia, Pennsylvania. Connect with research centers in your area.

All COVID-19 trials nationwide All trials in Philadelphia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 1-20 of 93 trials

WithdrawnOutpatient Use of Ivermectin in COVID-19Covid 19, a novel coronavirus, causes infection that, while mild to moderate in many people, can lead to severe disease in a significant portion.NCT04530474·Philadelphia, Pennsylvania CompletedAdaptive COVID-19 Treatment Trial 3 (ACTT-3)ACTT-3 will evaluate the combination of interferon beta-1a and remdesivir compared to remdesivir alone. Subjects will be assessed daily while hospitalized.NCT04492475·Birmingham, Alabama and 63 others

COVID-19 Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix San Antonio

Data from ClinicalTrials.govTerms

CompletedA Study to Evaluate the Safety and Immunogenicity of an (Omicron Subvariant) COVID-19 Vaccine Booster Dose in Previously Vaccinated Participants and Unvaccinated Participants.This is a Phase 2/3 open-label study to evaluate the safety and immunogenicity of a booster dose of the XBB.1.5 severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)…NCT05975060·Mobile, Alabama and 29 others

CompletedSafety and Anti-coronavirus Response of Suppression of Host Nucleotide Synthesis in Patients With COVID-19This will be a phase 1a randomized, open label, multi-center study with approximately 24 subjects.NCT04425252·Hartford, Connecticut and 4 others

WithdrawnSirolimus in COVID-19 Phase 1This is a double-blinded, two-arm, randomized, placebo controlled study comparing the virological efficacy of add-on sirolimus with standard care to placebo and standard care.NCT04371640·Philadelphia, Pennsylvania

CompletedParent Study: Study Understanding Pre-Exposure pRophylaxis of NOvel Anitbodies (SUPERNOVA) Sub-study: Study Understanding Pre-Exposure pRophylaxis of NOvel Anitbodies (SUPERNOVA Sub-study)AZD3152, a single mAb, is being developed to have broad neutralizing activity across known SARS-CoV-2 variants of concern for pre-exposure prophylaxis of COVID-19.NCT05648110·Birmingham, Alabama and 214 others

CompletedUnderstanding the Long-term Impact of COVID-19 in Adults (RECOVER)This is a combined retrospective and prospective, longitudinal, observational meta-cohort of individuals who will enter the cohort with and without SARS-CoV-2 infection and at…NCT05172024·Birmingham, Alabama and 85 others

CompletedPhase 3 Study of S-217622 in Prevention of Symptomatic SARS-CoV-2 InfectionThe purpose of this study is to measure the proportion of participants who are infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (positive reverse…NCT05897541·Birmingham, Alabama and 177 others

CompletedACTIV-6: COVID-19 Study of Repurposed Medications - Arm B (Fluvoxamine)The purpose of this study is to evaluate the effectiveness of repurposed medications (study drug(s) in reducing symptoms of non-hospitalized participants with mild to moderate…NCT05890586·Gilbert, Arizona and 90 others

Active not recruitingA Study to Evaluate the Efficacy and Safety of mRNA-1283 and mRNA-1273 in Participants 50 to 64 Years of Age Without High-Risk Conditions for Severe Coronavirus Disease 2019 (COVID-19)The purpose of this study is to evaluate the efficacy and safety of mRNA-1283 and mRNA-1273 (variant formulations) in adults 50 to 64 years of age without high risk factors for…NCT07266558·Birmingham, Alabama and 149 others

CompletedACTIV-6: COVID-19 Study of Repurposed Medications - Arm G (Metformin)The purpose of this study is to evaluate the effectiveness of repurposed medications (study drug(s) in reducing symptoms of non-hospitalized participants with mild to moderate…NCT06042855·Chandler, Arizona and 109 others

TerminatedStudy of the Efficacy and Safety of Intravenous Pamrevlumab, in Hospitalized Participants With Acute COVID-19 DiseaseThis study evaluates the efficacy and safety of intravenous (IV) infusions of pamrevlumab when compared with placebo in participants who are hospitalized with acute COVID-19…NCT04432298·Detroit, Michigan and 3 others

CompletedA Study to Investigate the Immunogenicity, Reactogenicity, and Safety of mRNA-1083 (Influenza and COVID-19) Vaccine in Adults ≥18 to <65 Years of AgeThe purpose of this study is to evaluate the immunogenicity, reactogenicity, and safety, of mRNA-1083 multicomponent influenza and COVID-19 vaccine in adults ≥18 to \<65 years of…NCT06864143·Scottsdale, Arizona and 16 others

RecruitingEfficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental OxygenThe purpose of this study is to evaluate the effect of tozorakimab, as an add-on to SoC in patients with viral lung infection requiring supplemental oxygen, on the prevention of…NCT05624450·Birmingham, Alabama and 467 others

Active not recruitingI-SPY COVID-19 TRIAL: An Adaptive Platform Trial for Critically Ill PatientsThe goal of this project is to rapidly screen promising agents, in the setting of an adaptive platform trial, for treatment of critically ill COVID-19 patients.NCT04488081·Birmingham, Alabama and 35 others

CompletedCOVID SAFE: COVID-19 Screening Assessment for ExposureIn order to safely and effectively reopen businesses and universities across the US, institutions will need to develop approaches to rapidly identify COVID-19 cases and manage…NCT04508777·Philadelphia, Pennsylvania

CompletedA Study to Evaluate The Efficacy, Safety and Immunogenicity of Inactivated SARS-CoV-2 Vaccines (Vero Cell) in Healthy Population Aged 18 Years Old and AboveThis is a multicenter, randomized, double blind, parallel placebo controlled, phase 3 clinical trial to evaluate the protective efficacy, safety and immunogenicity of inactivated…NCT04510207·Sanābis and 5 others

CompletedA Study to Learn About COVID-19 RNA-Based Variant-Adapted Vaccine Candidate(s) Against SARS-CoV-2 in Participants Ages 12 Through 64 Years Considered at Higher Risk of Severe COVID-19, and Participants Ages ≥65 YearsThe purpose of this study is to learn about the safety, tolerability, and immunogenicity of an updated vaccine against COVID-19.NCT07069309·Walnut Creek, California and 18 others

TerminatedA Study to Evaluate Efficacy and Safety of Casirivimab+Imdevimab (Monoclonal Antibodies) for Prevention of COVID-19 in Immunocompromised Adolescents and AdultsThe primary objective of the study is to evaluate the effect of casirivimab+imdevimab, compared with placebo, in preventing symptomatic SARS-CoV-2 infection in immunocompromised…NCT05074433·Birmingham, Alabama and 66 others

CompletedA Study to Evaluate Efficacy, Safety, and Immunogenicity of mRNA-1273 Vaccine in Adults Aged 18 Years and Older to Prevent COVID-19The mRNA-1273 vaccine is being developed to prevent COVID-19, the disease resulting from Severe Acute Respiratory Syndrome coronavirus (SARS-CoV-2) infection.NCT04470427·Birmingham, Alabama and 99 others

Page 1 of 5Next

Other Conditions in Philadelphia

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia